Insight into the Development of PET Radiopharmaceuticals for Oncology
While the development of positron emission tomography (PET) radiopharmaceuticals closely follows that of traditional drug development, there are several key considerations in the chemical and radiochemical synthesis, preclinical assessment, and clinical translation of PET radiotracers. As such, we o...
Saved in:
Published in | Cancers Vol. 12; no. 5; p. 1312 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI
21.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!